Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Acquisitions & Divestments (2016 - 2024)

Arcadia Biosciences (RKDA) has disclosed Change in Acquisitions & Divestments for 8 consecutive years, with $2.5 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Change in Acquisitions & Divestments rose 0.84% year-over-year to $2.5 million, compared with a TTM value of $5.0 million through Sep 2025, up 100.84%, and an annual FY2024 reading of $5.0 million, up 100.8% over the prior year.
  • Change in Acquisitions & Divestments was $2.5 million for Q4 2024 at Arcadia Biosciences, up from $2.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $15.2 million in Q1 2020 and bottomed at $1000.0 in Q4 2021.
  • Average Change in Acquisitions & Divestments over 4 years is $3.9 million, with a median of $2.5 million recorded in 2020.
  • Peak annual rise in Change in Acquisitions & Divestments hit 65.22% in 2020, while the deepest fall reached 87.76% in 2020.
  • Year by year, Change in Acquisitions & Divestments stood at $600000.0 in 2020, then crashed by 99.83% to $1000.0 in 2021, then soared by 250100.0% to $2.5 million in 2023, then increased by 0.84% to $2.5 million in 2024.
  • Business Quant data shows Change in Acquisitions & Divestments for RKDA at $2.5 million in Q4 2024, $2.5 million in Q4 2023, and $1000.0 in Q4 2021.